S3: Evolution of MDM2 and TP53 status over time of 5 patients affected by MDM2-amplified GBM. from Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas
作者
Maïté Verreault,Charlotte Schmitt,Lauriane Goldwirt,Kristine Pelton,Samer Haidar,Camille Levasseur,Jérémy Guehennec,David S. Knoff,Marianne Labussière,Yannick Marie,Azra Hadi Ligon,Karima Mokhtari,Khê Hoang‐Xuan,Marc Sanson,Brian Michael Alexander,Patrick Yung Wen,Jean‐Yves Delattre,Keith Lloyd Ligon,Ahmed Idbaïh